Integrated network pharmacology, molecular docking, and experimental validation to reveal the potential mechanism of Ginsenoside Rg1 on chronic obstructive pulmonary disease.

Li X, Xiang D, Hu L, Lin L, Wang G, Xu J

Open source

DOI
10.1038/s41598-026-63671-0
Published
2026 Jul 25
Container
Scientific reports
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41598-026-63671-0,
  title = {Integrated network pharmacology, molecular docking, and experimental validation to reveal the potential mechanism of Ginsenoside Rg1 on chronic obstructive pulmonary disease.},
  author = {Li X and Xiang D and Hu L and Lin L and Wang G and Xu J},
  year = {2026},
  journal = {Scientific reports},
  doi = {10.1038/s41598-026-63671-0},
  url = {https://doi.org/10.1038/s41598-026-63671-0}
}

RIS

TY  - JOUR
TI  - Integrated network pharmacology, molecular docking, and experimental validation to reveal the potential mechanism of Ginsenoside Rg1 on chronic obstructive pulmonary disease.
AU  - Li X
AU  - Xiang D
AU  - Hu L
AU  - Lin L
AU  - Wang G
AU  - Xu J
PY  - 2026
JO  - Scientific reports
DO  - 10.1038/s41598-026-63671-0
UR  - https://doi.org/10.1038/s41598-026-63671-0
ER  - 

APA

X, L., D, X., L, H., L, L., G, W., & J, X. (2026). Integrated network pharmacology, molecular docking, and experimental validation to reveal the potential mechanism of Ginsenoside Rg1 on chronic obstructive pulmonary disease.. Scientific reports. https://doi.org/10.1038/s41598-026-63671-0

Source records